1. Home
  2. NAMS vs VRN Comparison

NAMS vs VRN Comparison

Compare NAMS & VRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • VRN
  • Stock Information
  • Founded
  • NAMS 2019
  • VRN 1994
  • Country
  • NAMS Netherlands
  • VRN Canada
  • Employees
  • NAMS N/A
  • VRN N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • VRN Oil & Gas Production
  • Sector
  • NAMS Health Care
  • VRN Energy
  • Exchange
  • NAMS Nasdaq
  • VRN Nasdaq
  • Market Cap
  • NAMS 2.7B
  • VRN 3.2B
  • IPO Year
  • NAMS N/A
  • VRN N/A
  • Fundamental
  • Price
  • NAMS $18.57
  • VRN $5.01
  • Analyst Decision
  • NAMS Strong Buy
  • VRN Strong Buy
  • Analyst Count
  • NAMS 7
  • VRN 2
  • Target Price
  • NAMS $41.33
  • VRN $11.50
  • AVG Volume (30 Days)
  • NAMS 646.5K
  • VRN 17.1M
  • Earning Date
  • NAMS 03-04-2025
  • VRN 02-27-2025
  • Dividend Yield
  • NAMS N/A
  • VRN 6.68%
  • EPS Growth
  • NAMS N/A
  • VRN N/A
  • EPS
  • NAMS N/A
  • VRN 1.31
  • Revenue
  • NAMS $33,594,000.00
  • VRN $2,851,178,799.00
  • Revenue This Year
  • NAMS $131.53
  • VRN $31.20
  • Revenue Next Year
  • NAMS N/A
  • VRN N/A
  • P/E Ratio
  • NAMS N/A
  • VRN $3.87
  • Revenue Growth
  • NAMS 78.77
  • VRN 23.15
  • 52 Week Low
  • NAMS $15.19
  • VRN $4.39
  • 52 Week High
  • NAMS $27.29
  • VRN $9.28
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 29.65
  • VRN 47.64
  • Support Level
  • NAMS $18.88
  • VRN $5.14
  • Resistance Level
  • NAMS $20.46
  • VRN $5.38
  • Average True Range (ATR)
  • NAMS 1.11
  • VRN 0.17
  • MACD
  • NAMS -0.09
  • VRN 0.00
  • Stochastic Oscillator
  • NAMS 5.84
  • VRN 55.92

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About VRN Veren Inc. Common shares

Veren Inc is an oil producer company. It is engaged in acquiring, developing, and holding interests in petroleum assets operations across western Canada.

Share on Social Networks: